Sujata currently works as a Research Manager at IQVIA since 2019, where Sujata leads pharmacoeconomic modeling projects across diverse geographies including the Middle East, Africa, Japan, US and the Asia Pacific and supported more than 20 HTA submissions for various countries. Assisted African reimbursement authorities in designing and implementing health programs, ensuring the optimal allocation of resources and maximizing health outcomes. Her academic foundation includes a PhD in Economics from Jawaharlal Nehru University and a master’s in Quantitative Economics from the Indian Statistical Institute. Her career trajectory includes significant contributions to Complete HEOR Solutions as a Senior Analyst (2016-2019.) Core Competencies• Pharmacoeconomic Modeling: Expert in targeted and pragmatic literature reviews, developing cost-effectiveness and budget impact analyses, return on investment, multi-technology assessments, treatment sequencing models and burden of disease models. She has developed more than 25 comprehensive models and adapted around 70 models.• Evidence-Based Decision Making: Skilled in providing data-driven insights to reimbursement authorities for pricing negotiations and health program planning. Her work has been instrumental in shaping treatment guidelines and identifying patient subgroups for targeted therapies. Played a pivotal role in pricing negotiations by comparing budget impacts under various scenarios and facilitating outcome-based managed entry agreements in the Middle East.• Therapeutic understanding: Sujata has extensive experience across a wide range of therapeutic areas, including autoimmune diseases (e.g., Multiple Sclerosis, Atopic Dermatitis), cardiovascular conditions (e.g., CAD and PAD), oncology (e.g., Breast Cancer, NSCLC, Nasopharyngeal carcinoma, Prostate Cancer, Multiple Myeloma), and rare diseases (e.g., Sickle Cell Disease, Spinal Muscular Atrophy). Her background also encompasses endocrinology, gastrointestinal disorders (e.g., IBD), infectious diseases (e.g., HPV, Influenza), neurology (e.g., Epilepsy, Treatment-Resistant Depression), and respiratory conditions (e.g., ARDS, Asthma).• Collaborative Leadership: Proven leader in managing collaborations and engagements across multiple regions. Sujata has effectively coordinated with reimbursement authorities and pharmaceutical companies, supporting approximately 15 advisory boards and steering committee meetings.Her efforts have significantly contributed to the expansion of IQVIA’s footprint in the global health economics landscape.